Dr. Arlin Joel Silberman, DO

  • Chester, PA
  • Addiction psychiatry physician
NPI1346386299
Medicare services, 2019
72
Part D claims, 2024
4,607
Industry payments
$1,470
Affiliated sites
1
Medical group
1
Practice address
One Medical Center Boulevard, Upland, PA 19013
Practice phone
Call (610) 874-5257
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Prospect Health Access Network - Upland

Multi-specialty group site · Upland, Pennsylvania

Find Dr. Silberman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Arlin Joel Silberman is an addiction psychiatry physician in Chester, Pennsylvania

Dr. Silberman practices at Prospect Health Access Network - Upland in Upland, Pennsylvania.

Dr. Silberman's NPI, 1346386299, was assigned on January 29, 2007. Dr. Silberman holds Pennsylvania license OS03158L.

NPI and contact details
NPI enumeration date
January 29, 2007
NPI status
Active
Practice phone
(610) 874-5257
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Arlin Joel Silberman practices in Upland and Chester

Dr. Silberman's primary practice is Prospect Health Access Network - Upland, at One Medical Center Boulevard, Upland, PA 19013. The practice phone is (610) 874-5257. The NPI Registry lists Dr. Silberman's practice address as 1 Medical Center Blvd, Chester, PA 19013.

  • Prospect Health Access Network - UplandPrimary
    One Medical Center Boulevard, Upland, PA 19013Phone(610) 874-5257
  • NPI Registry address
    1 Medical Center Blvd, Chester, PA 19013 · Delaware CountyPhone(610) 874-5257

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data

Dr. Arlin Joel Silberman is affiliated with 1 site of care and 1 medical group

Dr. Silberman's primary practice is Prospect Health Access Network - Upland in Upland, Pennsylvania. The medical group on file is Crozer Health Medical Group (CHMG).

Prospect Health Access Network - UplandMulti-specialty group site · Upland, PennsylvaniaPrimary
Crozer Health Medical Group (CHMG)Primary care group, Chester, PA

Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dmand AI tracks the EHR system at Dr. Arlin Joel Silberman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silberman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Prospect Health Access Network - UplandAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Silberman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Arlin Joel Silberman is one of 22 addiction psychiatry physicians in Pennsylvania

Addiction psychiatry is Dr. Silberman's primary specialty in the NPI Registry, under taxonomy code 2084P0802X. Dr. Silberman is licensed in Pennsylvania.

Specialties and state licenses

  • Addiction psychiatry, PennsylvaniaPrimaryLicense OS03158L · taxonomy 2084P0802X

Addiction psychiatry physicians near Dr. Silberman

Counts of addiction psychiatry physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Arlin Joel Silberman billed Medicare for 72 services in 2019

CMS data shows 72 Medicare services from Dr. Silberman across 1 procedure code in 2019, all of them office visits. Medicare paid $3,033 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 201972
Paid by Medicare$3,033
Procedure codes1

Dr. Silberman's Medicare services by type, 2018 to 2019

  • 2018
  • 2019
Office and hospital visits
2018: 1062019: 7232%

Dr. Silberman compared with the Pennsylvania median for addiction psychiatry physicians, 2019

  • Dr. Silberman
  • Pennsylvania median
Medicare services
72vs 72Close to median
Part D claims
4,530vs 24218.7 times

Medians across 21 addiction psychiatry physicians in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Silberman's most billed Medicare procedure codes, 2019

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Silberman

Need commercial claims for Dr. Silberman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Silberman and other addiction psychiatry physicians in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Arlin Joel Silberman wrote 4,607 Medicare Part D claims in 2024

In 2024, Dr. Silberman wrote 4,607 Medicare Part D claims for 237 patients. 95% of them were for generic drugs. CMS names the drug for 4,530 of them, across 57 drugs with 11 or more claims each, at $480,117 in total drug cost. In 2023, CMS named 2,132 claims across 41 drugs.

Part D claims, 20244,607
Drugs named by CMS57
Total drug cost$480,117
Part D patients237

Dr. Silberman's Part D claims by kind of drug, 2024

  • Generic4,392 claims95%
  • Brand-name215 claims5%

Dr. Silberman's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Silberman's Part D claims, 2024

  • Antipsychotics, patients 65 and over11%484 of 4,607 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2,1322024: 4,530112%

Drugs named by CMS: 57 in 2024, 41 in 2023.

See all prescribing by Dr. Silberman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find addiction psychiatry physicians like Dr. Silberman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Arlin Joel Silberman received $1,470 in industry payments from 2016 to 2025

CMS Open Payments shows 73 general payments to Dr. Silberman from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $258.

General payments to Dr. Silberman by program year, 2016 to 2025

Companies that paid Dr. Silberman the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Silberman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Arlin Joel Silberman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Arlin Joel Silberman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Arlin Joel Silberman's NPI number?

Dr. Arlin Joel Silberman's NPI number is 1346386299. It was assigned on January 29, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Arlin Joel Silberman?

Dr. Arlin Joel Silberman is an addiction psychiatry physician in Chester, Pennsylvania. The primary specialty in the NPI Registry is Addiction Psychiatry Physician (taxonomy code 2084P0802X).

Where does Dr. Arlin Joel Silberman practice?

Dr. Silberman practices at One Medical Center Boulevard, Upland, PA 19013. Dr. Silberman also practices at 1 Medical Center Blvd, Chester, PA 19013. Dr. Silberman's primary practice is Prospect Health Access Network - Upland in Upland, Pennsylvania.

What is Dr. Arlin Joel Silberman's office phone number?

The practice phone on file for Dr. Silberman is (610) 874-5257.

What is Dr. Arlin Joel Silberman's medical license number?

Dr. Silberman holds Pennsylvania license OS03158L.

What medical group is Dr. Arlin Joel Silberman part of?

Dr. Silberman is linked to Crozer Health Medical Group (CHMG).

Does Dr. Arlin Joel Silberman accept Medicare?

Yes. CMS data shows Dr. Silberman billed Medicare for 72 services in 2019.

What services does Dr. Arlin Joel Silberman bill to Medicare?

In 2019, Dr. Silberman's most billed Medicare services were office visit, established patient (99213).

What drugs does Dr. Arlin Joel Silberman prescribe most?

In 2024 Medicare Part D data, Dr. Silberman's most prescribed drugs by claims were Quetiapine Fumarate, Clonazepam and Trazodone HCl.

Has Dr. Arlin Joel Silberman received payments from drug or device companies?

CMS Open Payments shows $1,470 in general payments to Dr. Silberman from 15 companies from 2016 to 2025. The largest total came from Otsuka America Pharmaceutical, Inc.

How long has Dr. Arlin Joel Silberman been practicing?

Dr. Silberman's NPI was assigned in 2007.

Selling to addiction psychiatry practices?

See addiction psychiatry physicians in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)